Compare VNCE & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNCE | HBIO |
|---|---|---|
| Founded | 2002 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 24.9M |
| IPO Year | 2013 | 2000 |
| Metric | VNCE | HBIO |
|---|---|---|
| Price | $4.20 | $5.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $5.17 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 253.9K | 28.4K |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.45 | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $300,007,000.00 | $116,176,000.00 |
| Revenue This Year | $5.86 | $4.77 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | $8.55 | ★ N/A |
| Revenue Growth | ★ 2.23 | N/A |
| 52 Week Low | $1.19 | $0.28 |
| 52 Week High | $5.90 | $7.50 |
| Indicator | VNCE | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.46 | 47.35 |
| Support Level | $4.00 | $4.42 |
| Resistance Level | $4.43 | $5.79 |
| Average True Range (ATR) | 0.47 | 0.46 |
| MACD | -0.12 | -0.18 |
| Stochastic Oscillator | 13.54 | 24.52 |
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.